Kestra Medical Technologies, Ltd.
KMTS
$16.55
-$0.42-2.48%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.82M | 52.64M | 45.82M | 36.82M | 27.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.82M | 52.64M | 45.82M | 36.82M | 27.81M |
| Cost of Revenue | 35.61M | 34.66M | 33.52M | 30.48M | 27.45M |
| Gross Profit | 24.21M | 17.97M | 12.31M | 6.33M | 362.00K |
| SG&A Expenses | 114.94M | 82.40M | 75.70M | 72.82M | 69.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 166.19M | 131.15M | 123.68M | 118.28M | 112.88M |
| Operating Income | -106.38M | -78.52M | -77.86M | -81.46M | -85.06M |
| Income Before Tax | -113.68M | -84.98M | -84.85M | -89.47M | -94.10M |
| Income Tax Expenses | 135.00K | 6.00K | 2.00K | 13.00K | 24.00K |
| Earnings from Continuing Operations | -113.81 | -84.99 | -84.85 | -89.48 | -94.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 942.00K | 692.00K | 346.00K | -- |
| Net Income | -113.81M | -84.05M | -84.16M | -89.14M | -94.12M |
| EBIT | -106.38M | -78.52M | -77.86M | -81.46M | -85.06M |
| EBITDA | -98.41M | -68.88M | -66.75M | -70.13M | -73.50M |
| EPS Basic | -437.85 | -436.82 | -436.75 | -470.65 | -504.55 |
| Normalized Basic EPS | -237.23 | -236.54 | -236.55 | -259.12 | -281.69 |
| EPS Diluted | -437.85 | -436.82 | -436.75 | -470.65 | -504.55 |
| Normalized Diluted EPS | -237.23 | -236.54 | -236.55 | -259.12 | -281.69 |
| Average Basic Shares Outstanding | 44.68M | 39.98M | 39.98M | 39.98M | 39.98M |
| Average Diluted Shares Outstanding | 44.68M | 39.98M | 39.98M | 39.98M | 39.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |